Search

everythinglearnresearchcommunity

for

Search:↓

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Male pattern baldness is common, treatable, and may be linked to heart disease and prostate cancer.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Precise objectives can improve student achievement in health education.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

High uric acid can cause health problems, but lifestyle changes can help manage it.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Finasteride is effective for hair loss but has controversial side effects.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

The compound was successfully made and shows potential for treating prostate cancer.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

The document covers various male health issues, their causes, treatments, and related conditions.